Article Information
History
- April 12, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Juliette H Lanskey1,*,
- Amirhossein Jafarian1,2,
- Melek Karadag2,
- Ece Kocagoncu2,
- Rebecca Williams1,
- Pranay Yadav1,
- Andrew J Quinn3,4,
- Jemma Pitt4,
- Tony Thayanandan4,
- Stephen Lowe5,
- Michael Perkinton6,
- Maarten Timmers7,
- Vanessa Raymont8,
- Krish D Singh9,
- Mark Woolrich4,
- Anna C Nobre4,
- Richard N Henson1,10,
- James B Rowe1,2,
- the NTAD study group
- 1MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
- 2Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK
- 3Centre for Human Brain Health, School of Psychology, University of Birmingham, UK
- 4Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, UK
- 5Lilly Corporate Center, Indianapolis, USA
- 6Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
- 7Neuroscience External Innovation, Johnson & Johnson Innovations, London, UK
- 8Department of Psychiatry, University of Oxford, Oxford, UK
- 9Cardiff University Brain Research Imaging Centre, School of Psychology, Cardiff University, Cardiff, UK
- 10Department of Psychiatry, University of Cambridge, Cambridge, UK
- ↵*Correspondence to: Juliette Lanskey, MRC Cognition and Brain Sciences Unit, University of Cambridge, 15 Chaucer Road, Cambridge, CB2 7EF, Juliette.lanskey{at}mrc-cbu.cam.ac.uk
Posted April 12, 2024.
The effect of Alzheimer’s disease and its progression on pyramidal cell gain and connectivity
